Kenneth S. Koblan
Sumitomo Dainippon Pharma (United States)(US)
Publications by Year
Research Areas
Protein Kinase Regulation and GTPase Signaling, Receptor Mechanisms and Signaling, Schizophrenia research and treatment, Neurotransmitter Receptor Influence on Behavior, Neuroscience and Neuropharmacology Research
Most-Cited Works
- → Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice(1995)538 cited
- → A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia(2020)284 cited
- → Chronic neuropathic pain is accompanied by global changes in gene expression and shares pathobiology with neurodegenerative diseases(2002)253 cited
- → Receptor Activity-modifying Protein 1 Determines the Species Selectivity of Non-peptide CGRP Receptor Antagonists(2002)190 cited
- → A Farnesyltransferase Inhibitor Induces Tumor Regression in Transgenic Mice Harboring Multiple Oncogenic Mutations by Mediating Alterations in Both Cell Cycle Control and Apoptosis(1998)172 cited
- → SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D2 Receptor Mechanism of Action(2019)168 cited